Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(66.7%)
N/A
1(33.3%)
3Total
Phase 4(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05523856Active Not Recruiting

New Treatment Modalities for Localized Prostate Cancer

Role: collaborator

NCT02224066Phase 4Completed

Platelet Reactivity After TAVI: A Multicenter Pilot Study

Role: lead

NCT02745314Completed

Frailty and Mortality in Older Old With Severe Aortic Stenosis

Role: lead

NCT01076465Not ApplicableCompleted

Efficacy of a Disease Management Program in Very Old Patients With Heart Failure

Role: lead

NCT00755443Phase 4Completed

Sirolimus-Eluting Stent Versus Standard Stent in Diabetic

Role: collaborator

All 5 trials loaded